NAFDAC: Camosunate not Banned in Nigeria

NAFDAC says that Camosunate is not banned in Nigeria (News Central TV) NAFDAC says that Camosunate is not banned in Nigeria (News Central TV)
NAFDAC says that Camosunate is not banned in Nigeria. Credit: The Guardian Nigeria News

The National Agency for Food and Drug Administration and Control (NAFDAC) dismissed social media claims on Saturday that authorities had banned the antimalarial drug Camosunate in Nigeria.

Director-General Prof. Mojisola Adeyeye signed the press release rejecting the rumours and telling Nigerians to ignore false reports about Camosunate or artesunate-amodiaquine medicines.

“The Agency clarifies that it has never banned Camosunate or medicines containing the artesunate-amodiaquine combination,” the statement read.

NAFDAC noted that symptoms cited in viral posts may match known side effects of the medication rather than signal a ban.

“Some of the symptoms reported in the viral claim may be associated with known side effects of Camosunate, including nausea, vomiting, diarrhoea, abdominal pain, headache, dizziness, drowsiness and loss of appetite,” the release stated.

NAFDAC says that Camosunate is not banned in Nigeria (News Central TV)
NAFDAC says that Camosunate is not banned in Nigeria.
 Credit: Emzor Pharmaceutical Industries Limited/Facebook

Instead of spreading unverified claims online, the agency urged citizens and health workers to report suspected side effects for formal review.

“However, suspected adverse drug reactions should be reported to NAFDAC for proper assessment,” the statement added. People can submit reports via the Med Safety App on Android or iOS devices or visit the nearest NAFDAC office.

The regulator also called on Nigerians to halt the spread of misinformation across social platforms.

“NAFDAC urges the public to stop circulating the false claim. Those who have already shared it are encouraged to disseminate this clarification through the same channels to help counter misinformation and prevent unnecessary public concern,” the agency stated.

Author

  • Abisoye Adeyiga

    Abisoye Adedoyin Adeyiga holds a PhD in Languages and Media Studies and a Master’s in Education (English Language). Trained in digital marketing and investigative journalism, she is passionate about new media’s transformative power. She enjoys reading, traveling, and meaningful conversations.

Share the Story

More From News Central TV

Advertisement

Keep Up to Date with the Most Important News

Weekly roundups. Sharp analysis. Zero noise.
The NewsCentral TV Newsletter delivers the headlines that matter—straight to your inbox, keeping you updated regularly.

×